Abstract
Neuroblastomas are characterized by 1p deletions, suggesting that a tumor suppressor gene (TSG) resides in this region. We have mapped the smallest region of deletion (SRD) to a 2 Mb region of 1p36.31 using microsatellite and single nucleotide polymorphisms. We have identified 23 genes in this region, and we have analysed these genes for mutations and RNA expression patterns to identify candidate TSGs. We sequenced the coding exons of these genes in 30 neuroblastoma cell lines. Although rare mutations were found in 10 of the 23 genes, none showed a pattern of genetic change consistent with homozygous inactivation. We examined the expression of these 23 genes in 20 neuroblastoma cell lines, and most showed readily detectable expression, and no correlation with 1p deletion. However, 7 genes showed uniformly low expression in the lines, and 2 genes (CHD5, RNF207) had virtually absent expression, consistent with the expected pattern for a TSG. Our mutation and expression analysis in neuroblastoma cell lines, combined with expression analysis in normal tissues, putative function and prior implication in neuroblastoma pathogenesis, suggests that the most promising TSG deleted from the 1p36 SRD is CHD5, but TNFRSF25, CAMTA1 and AJAP1 are also viable candidates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D et al. (2005). Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353: 2243–2253.
Bader SA, Fasching C, Brodeur GM, Stanbridge EJ . (1991). Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2: 245–255.
Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D et al. (2007). CHD5 is a tumor suppressor at human 1p36. Cell 128: 459–475.
Bauer A, Savelyeva L, Claas A, Praml C, Berthold F, Schwab M . (2001). Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosomes Cancer 31: 228–239.
Bergo MO, Gavino BJ, Hong C, Beigneux AP, McMahon M, Casey PJ et al. (2004). Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest 113: 539–550.
Brodeur GM . (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203–216.
Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA . (1981). Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41: 4678–4686.
Brodeur GM, Maris JM . (2006). Neuroblastoma. In: Pizzo Pa, Poplack Dg (eds). Principles and Practice of Pediatric Oncology. Lippincott Williams & Wilkins: Philadelphia, pp 933–970.
Brodeur GM, Sekhon G, Goldstein MN . (1977). Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256–2263.
Buetow KH, Edmonson MN, Cassidy AB . (1999). Reliable identification of large numbers of candidate SNPs from public EST data. Nat Genet 21: 323–325.
Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G et al. (1995). Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4: 535–539.
Caron H, Spieker N, Godfried M, Veenstra M, van Sluis P, de Kraker J et al. (2001). Chromosome bands 1p35–36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30: 168–174.
Chen YZ, Soeda E, Yang HW, Takita J, Chai L, Horii A et al. (2001). Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36. Genes Chromosomes Cancer 31: 326–332.
Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F et al. (1995). Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35–36 region, only one of which is associated with N-myc amplification. Oncogene 10: 291–297.
Eggert A, Grotzer MA, Zuzak TJ, Ikegaki N, Zhao H, Brodeur GM . (2002). Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system. Eur J Cancer 38: 92–98.
Elia A, Vyas J, Laing KG, Clemens MJ . (2004). Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein–Barr virus small RNA EBER-1. Eur J Biochem 271: 1895–1905.
Fok V, Mitton-Fry RM, Grech A, Steitz JA . (2006). Multiple domains of EBER 1, an Epstein–Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 12: 872–882.
Gehring M, Berthold F, Edler L, Schwab M, Amler LC . (1995). The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res 55: 5366–5369.
Grenet J, Valentine VA, Kitson J, Li H, Farrow SN, Kidd VJ . (1998). Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma. Genomics 49: 385–393.
Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS . (2005). A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 37: 549–554.
Henrich KO, Claas A, Praml C, Benner A, Mollenhauer J, Poustka A et al. (2007). Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma. Eur J Cancer 43: 607–616.
Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B et al. (2006). Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res 12: 131–138.
Ho R, Minturn JE, Hishiki T, Zhao H, Wang Q, Cnaan A et al. (2005). Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res 65: 9868–9875.
Katoh M, Katoh M . (2003). Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23. Int J Oncol 23: 1219–1224.
Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA et al. (1997). Human Kruppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene? Eur J Cancer 33: 1991–1996.
Martinsson T, Sjoberg RM, Hallstensson K, Nordling M, Hedborg F, Kogner P . (1997). Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. Eur J Cancer 33: 1997–2001.
Martinsson T, Sjoberg RM, Hedborg F, Kogner P . (1995). Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55: 5681–5686.
McDonald JM, Dunmire V, Taylor E, Sawaya R, Bruner J, Fuller GN et al. (2005). Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss. Mol Cancer 4: 35.
Ohira M, Kageyama H, Mihara M, Furuta S, Machida T, Shishikura T et al. (2000). Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19: 4302–4307.
Oliphant A, Barker DL, Stuelpnagel JR, Chee MS . (2002). BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 56–58 (Suppl): 60–61.
Rozen S, Skaletsky H . (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365–386.
Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM et al. (1994). Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10: 275–281.
Steemers FJ, Chang W, Lee G, Barker DL, Shen R, Gunderson KL . (2006). Whole-genome genotyping with the single-base extension assay. Nat Methods 3: 31–33.
Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M et al. (1994). There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10: 30–39.
Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM . (2003). CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 22: 1002–1011.
Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM et al. (2001). Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Cancer Res 61: 679–686.
Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D et al. (2006). Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 66: 6050–6062.
White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M et al. (1995). A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92: 5520–5524.
White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M et al. (2005). Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24: 2684–2694.
Winter-Vann AM, Baron RA, Wong W, dela Cruz J, York JD, Gooden DM et al. (2005). A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proc Natl Acad Sci USA 102: 4336–4341.
Acknowledgements
This work was supported in part by a grant from the NIH (R01-CA039771; GMB) and the Audrey E Evans Endowed Chair in Molecular Oncology (GMB). We are grateful to Juan Perin from the Bioinformatics Core for assistance in the sequence analysis of candidate TSGs.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okawa, E., Gotoh, T., Manne, J. et al. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas. Oncogene 27, 803–810 (2008). https://doi.org/10.1038/sj.onc.1210675
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210675
Keywords
This article is cited by
-
Chromosome 1p36 candidate gene ZNF436 predicts the prognosis of neuroblastoma: a bioinformatic analysis
Italian Journal of Pediatrics (2023)
-
The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells
BMC Cancer (2023)
-
Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma
BMC Cancer (2022)
-
CHD5 inhibits metastasis of neuroblastoma
Oncogene (2022)
-
Exome sequencing identifies a novel nonsense mutation of Ring Finger Protein 207 in a Chinese family with Long QT syndrome and syncope
Journal of Human Genetics (2019)